Drug Database
Back to search

Poland· PL-100309734

Fluenz Tetra

A influenza, lebend abgeschwächt product containing szczepionka przeciw grypie (żywa atenuowana, do nosa), registered in Poland by AstraZeneca AB. The same ATC class is registered in 10 of our 19 countries.

ATC J07BB03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFluenz TetraATCJ07BB03REGISTER NO.PL-100309734PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about szczepionka przeciw grypie (żywa atenuowana, do nosa)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Influenza, lebend abgeschwächt is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BB03 (influenza, lebend abgeschwächt), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search influenza, lebend abgeschwächt products by name

Influenza, lebend abgeschwächt · ATC J07BB03

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw grypie (żywa atenuowana, do nosa)
Manufacturer
AstraZeneca AB
Country
Poland (PL)
ATC code
J07BB03
ATC class
Influenza, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05000456054294
  • gtin
    05000456061346

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BB03

Influenza, lebend abgeschwächt, as other registers publish it.

All influenza, lebend abgeschwächt products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee111bce-d03b-448d-8640-951952895d97
GET /v1/drugs/ee111bce-d03b-448d-8640-951952895d97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol do nosa, zawiesina",
  "source": "urpl",
  "strength": "1 dawka 0,2 ml",
  "packaging": "Rp ¦ Skasowane ¦ EU/1/13/887/001 ¦ 88873\n10 aplikatorów 0,2 ml\n05000456054294 ¦ Rp ¦ Skasowane ¦ EU/1/13/887/003 ¦ 119816\n1 aplikator 0,2 ml\nRp ¦ Skasowane ¦ EU/1/13/887/002 ¦ 119817\n1 aplikator 0,2 ml\nRp ¦ EU/1/13/887/004 ¦ 119818\n10 aplikatorów 0,2 ml\n05000456061346 ¦ Rp ¦ EU/1/13/887/003 ¦ 136118\n1 aplikator 0,2 ml",
  "substance": "A/Victoria/4897/2022 (H1N1)pdm09 – podobny szczep (A/Victoria/4897/2022, IVR238) 10^7,0±0,5 FFU",
  "common_name": "Szczepionka przeciw grypie (żywa atenuowana, do nosa)",
  "pl_product_id": "100309734",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": "2025-07-14"
}
API referenceMCP serverPlans

See everything about influenza, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console